Literature DB >> 3781559

Partial adenosine deaminase deficiency: another family from southern Africa.

S L Hart, A B Lane, T Jenkins.   

Abstract

Adenosine deaminase (ADA) from a partially ADA-deficient Xhosa man has been characterized. This is only the second such case described in southern Africa, the previous one being a Kalahari San ("Bushman"). Red blood cell ADA levels were found to be only 6-9% of normal whereas his white cell ADA levels were much higher at 30% of normal. The stability of the enzyme at 57 degrees C was shown to be greatly decreased indicating a mutation resulting in an enzyme with decreased stability in vivo. The Michaelis constant (Km) for adenosine was found to be normal. Deoxy-ATP levels in the red cells were elevated 2- to 3-times above normal, although this appears to be of no immunological consequence. Starch gel electrophoresis of red cell ADA from family members of the index case, in conjunction with red cell ADA activity levels, suggested that both parents carried a gene for partial ADA deficiency. Isoelectric focusing studies suggested that the two parental partial ADA-deficiency genes were not the same. Electrophoretic studies also revealed that another rare allele of ADA, possibly ADA*5, was segregating within the same family although this event appears to be unconnected with the ADA partial deficiency. A Xhosa population sample was assayed for red cell ADA activity. The results suggested a frequency of 0.015 +/- 0.010 for ADA partial-deficiency alleles, although the number of different alleles involved is not known.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3781559     DOI: 10.1007/bf00282554

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  The deaminases of adenosine and adenylic acid in blood and tissues.

Authors:  E J Conway; R Cooke
Journal:  Biochem J       Date:  1939-04       Impact factor: 3.857

2.  A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA.

Authors:  A W Solter; R E Handschumacher
Journal:  Biochim Biophys Acta       Date:  1969-02-18

3.  [Genetic of erythrocyte adenosine deaminase. Gene frequencies and family studies].

Authors:  W Renninger; C Bimboese
Journal:  Humangenetik       Date:  1970

4.  Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

Review 5.  Biochemistry of diseases of immunodevelopment.

Authors:  D W Martin; E W Gelfand
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 6.  Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.

Authors:  R Hirschhorn; H Ratech
Journal:  Curr Top Hematol       Date:  1983

7.  Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.

Authors:  P E Daddona; W N Kelley
Journal:  Biochim Biophys Acta       Date:  1981-04-14

8.  Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.

Authors:  D Valerio; M G Duyvesteyn; H van Ormondt; P Meera Khan; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

9.  Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.

Authors:  J L Perignon; M Hamet; P Cartier; C Griscelli
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

10.  Genetic heterogeneity in partial adenosine deaminase deficiency.

Authors:  R Hirschhorn; F Martiniuk; V Roegner-Maniscalco; A Ellenbogen; J L Perignon; T Jenkins
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  1 in total

Review 1.  Adenosine deaminase deficiency: a review.

Authors:  Aisling M Flinn; Andrew R Gennery
Journal:  Orphanet J Rare Dis       Date:  2018-04-24       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.